MRK (STOCKS)
Merck & Co., Inc.
$118.150000
+1.000000 (+0.85%)
Prev close: $117.150000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert M. Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $295,931.24M
- Employees
- 75,000
- P/E (TTM)
- 16.09
- P/B (TTM)
- 5.62
- Dividend Yield
- 279.98%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $64.24B |
| Benefits Costs and Expenses | $42.42B |
| Cost Of Revenue | $14.66B |
| Costs And Expenses | $42.42B |
| Gross Profit | $49.58B |
| Operating Expenses | $27.76B |
| Selling, General, and Administrative Expenses | $10.70B |
| Research and Development | $16.49B |
| Other Operating Expenses | $573.00M |
| Operating Income/Loss | $21.82B |
| Income/Loss From Continuing Operations After Tax | $19.04B |
| Income/Loss From Continuing Operations Before Tax | $21.82B |
| Income Tax Expense/Benefit | $2.77B |
| Income Tax Expense/Benefit, Deferred | -$1.46B |
| Net Income/Loss | $19.04B |
| Net Income/Loss Attributable To Noncontrolling Interest | $10.00M |
| Net Income/Loss Attributable To Parent | $19.03B |
| Net Income/Loss Available To Common Stockholders, Basic | $19.03B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.57 |
| Diluted Earnings Per Share | $7.57 |
| Basic Average Shares | 7,526,000,000 |
| Diluted Average Shares | 7,540,000,000 |
| Assets | $129.55B |
| Current Assets | $47.56B |
| Inventory | $6.44B |
| Other Current Assets | $41.11B |
| Noncurrent Assets | $81.99B |
| Fixed Assets | $25.64B |
| Intangible Assets | $15.31B |
| Other Non-current Assets | $41.04B |
| Liabilities | $77.64B |
| Current Liabilities | $28.63B |
| Accounts Payable | $4.15B |
| Other Current Liabilities | $24.48B |
| Noncurrent Liabilities | $49.01B |
| Equity | $51.91B |
| Equity Attributable To Noncontrolling Interest | $57.00M |
| Equity Attributable To Parent | $51.85B |
| Liabilities And Equity | $129.55B |
| Net Cash Flow From Operating Activities | $17.07B |
| Net Cash Flow From Operating Activities, Continuing | $17.07B |
| Net Cash Flow From Investing Activities | -$3.98B |
| Net Cash Flow From Investing Activities, Continuing | -$3.98B |
| Net Cash Flow From Financing Activities | -$9.68B |
| Net Cash Flow From Financing Activities, Continuing | -$9.68B |
| Exchange Gains/Losses | $173.00M |
| Net Cash Flow | $3.57B |
| Net Cash Flow, Continuing | $3.40B |
| Comprehensive Income/Loss | $19.20B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $19.20B |
| Other Comprehensive Income/Loss | $169.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $169.00M |